Genetic aberrations in oral or head and neck squamous cell carcinoma 3: Clinico-pathological applications

Oral Oncology

Volumn 36, Issue 5, 2000, Pages 404-413

  Scully, C ^a   Field, J K ^b,c   Tanzawa, H ^d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c Roy Castle International Centre for Lung Cancer Research   (United Kingdom)

^d CHIBA UNIVERSITY   (Japan)

Author keywords

Cancer; Chromosomes; Genetics; Oral

Indexed keywords

CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CANCER STAGING; CHROMOSOME ABERRATION; DISEASE MARKER; HEAD CANCER; HISTOPATHOLOGY; MOUTH CARCINOMA; NECK CANCER; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SQUAMOUS CELL CARCINOMA;

EID: 0033842054     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(00)00023-3     Document Type: Article

References (184)

1. Scully C, Field J.K, Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN), 1 Carcinogen metabolism, DNA repair and cell cycle control. Oral Oncology 2000;36:256-63.
2. Scully C, Field J.K, Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN), 2 Chromosomal aberrations. Oral Oncology 2000;36:311-27.
3. Sidransky D. Molecular genetics of head and neck cancer. Current Opinion in Oncology. 7:1995;229-233.
4. Bradford C.R. Predictive factors in head and neck cancer. Hematol Oncol Clin North Amer. 13:1999;777-785.
5. Mao L., Lee D.J., Tockman M.S., Erozan Y.S., Askin F., Sidransky D. Microsatellite alterations as clonal markers in the detection of human cancers. Proc Natl Acad Sci. 91:1994;9871-9875.
6. Brennan J.A., Sidransky D. Molecular staging of head and neck squamous carcinoma. Cancer Metastasis Rev. 15:1996;3-10.
7. Scully C., Burkhardt A. Tissue markers of potentially malignant oral epithelial lesions. Journal of Oral Pathology and Medicine. 22:1993;246-256.
8. Papadimitrakopoulou V.A., Shin D.M., Hong W.K. Molecular and cellular biomarkers for field cancerization and multistep process in head and neck tumorigenesis. Cancer Metastasis Rev. 15:1996;53-76.
9. Oh Y., Mao L. Biomarkers in head and neck carcinoma. Current Opinion in Oncology. 9:1997;247-256.
10. Field J.K., Spandidos D.A., Stell P.M. Overexpression of the p53 gene in head and neck cancer, linked with heavy smoking and drinking. Lancet. 339:1992;502-503.
11. Ogden G.R., Kiddie R.A., Lunny D.P., Lane D.P. Assessment of p53 protein expression in normal, benign and malignant oral mucosa. J Pathol. 166:1992;389-394.
12. Smith M.L., Yin X.Y., Whiteside T.L., Johnson J.T., Herberman Rb., Locker J. Abnormalities in the p53 gene in tumors and cell lines of human squamous cell carcinomas of the head and neck. Proc Am Assoc Cancer Res. 33:1992;387.
13. Lazarus P., Stern J., Zwiebel N., Fair A., Richie J.P. Jr., Schantz S. Relationship between p53 mutation incidence in oral cavity squamous cell carcinomas and patient tobacco use. Carcinogenesis. 17:1996;733-739.
14. Field J.K., Zoumpourlis V., Spandidos D.A., Jones A.S. P53 expression and mutations in squamous cell carcinoma of the head and neck: expression correlates with the patients use of tobacco and alcohol. Cancer Detect Prev. 18:1994;197-208.
15. Brennan J.A., Boyle J.O., Koch W.M., Goodman S.N., Hruban R.H., Eby Y.J, et al. Association between cigarette smoking and mutation of the p53 gene in squamous cell carcinoma of the head and neck. New Engl J Med. 332:1995;712-717.
16. Lazarus P., Garewal H.S., Sciubba J., Zwiebel N., Calcagnotto A., Fair A, et al. A low incidence of p53 mutations in pre-malignant lesions of the oral cavity from non-tobacco users. Int J Cancer. 60:1995;458-463.
17. Hogmo A., Munck-Wikland E., Kuylenstierna R., Lindholm J., Auer G. Nuclear DNA content and p53 immunostaining in oral squamous cell carcinoma - an analysis of a consecutive 10 year material. Int J Oncol. 5:1994;915-920.
18. Zariwala M., Schmid S., Pfaltz M., Ohgaki H., Kleihues P., Schafer R. p53 gene mutations in oropharyngeal carcinomas: a comparison of solitary and multiple primary tumors and lymph-node metastases. Int J Cancer. 56:1994;807-811.
19. Nakanishi Y., Noguchi M., Matsuno Y., Saikawa M., Mukai K., Shimosato Y, et al. p53 expression in multicentric squamous cell carcinoma and surrounding squamous epithelium of the upper aerodigestive tract. Cancer. 75:1995;1657-1662.
20. Franceschi S., Gloghini A., Maestro R., Barzan L., Bidoli E., Talamini R.et al. Analysis of the p53 gene in relation to tobacco and alcohol in cancers of the upper aero-digestive tract. Int J Cancer. 60:1995;872-876.
21. Matthews J.B., Scully C., Jovanovic A., Van der Waal I., Yeudall W.A., Prime S.S. Relationship of tobacco/alcohol use to p53 expression in patients with lingual squamous cell carcinomas. Oral Oncols Eur J Cancer. 29B:1993;285-289.
22. Yan J.J., Tzeng C.C., Jin Y.T. Overexpression of p53 protein in squamous cell carcinoma of buccal mucosa and tongue in Taiwan: an immunohistochemical and clinicopathological study. J Oral Pathol Med. 25:1996;55-59.
23. Van Oijen M.G.C.T., Van de Craats J.G., Slootweg P.J. P53 overexpression in oral mucosa in relation to smoking. J Pathol. 187:1999;469-474.
24. Shin D.M., Kim J., Ro J.Y., Hittelman J., Roth J.A., Hong W.K, et al. Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis. Cancer Res. 54:1994;321-326.
25. Nees M., Homann N., Discher H., Andl T., Enders C, Herold-Meude E, et al. Expression of mutated p53 occurs in tumor-distant epithelia of head and neck cancer patients: a possible molecular basis for the development of multiple tumors. Cancer Res. 53:1993;4189-4196.
26. Waridel F., Estreicher A., Bron L, Flaman JM, Fontolliet C, Monnier P, et al Field cancerisation and polyclonal p53 mutation in the upper areodigestive tract. Oncogene. 14:1997;163-169.
27. Liloglou T., Scholes A.G.M., Spandidos D.A., Vaughan E.D., Jones A.S., Field J.K. P53 mutations in squamous cell carcinoma of the head and neck predominate in a subgroup of former and present smokers with a low frequency of genetic instability. Cancer Res. 57:1997;4070-4074.
28. Sorensen D.M., Lewark T.M., Haney J.L., Meyers A.D., Krause G., Franklin W.A. Absence of p53 mutations in squamous carcinomas of the tongue in nonsmoking and nondrinking patients younger than 40 years. Arch Otolaryngol Head Neck Surg. 123:1997;503-506.
29. Field J.K., Kiaris H., Risk J.M., Tsiriyotis C., Adamson R., Zoumpourlis V, et al. Allelotype of squamous cell carcinoma of the head and neck: fractional allele loss correlates with survival. Br J Cancer. 72:1995;1180-1188.
30. Kaur J., Srivastava A., Ralhan R. Prognostic significance of p53 protein over-expression in betel and tobacco related oral oncogenesis. Int J Cancer. 79:1998;370-375.
31. Chiba I., Muthumala M., Yamazaki Y., Zaman A.U., Iizuka T., Amamiya A, et al. Characteristics of mutations in the p53 gene of oral squamous-cell carcinomas associated with betel-quid chewing in Sri Lanka. Int J Cancer. 77:1998;839-842.
32. Kaur J., Srivastava A., Ralhan R. Overexpression of p53 protein in betel- and tobacco-related human oral dysplasia and squamous cell carcinoma in India. Int J Cancer. 58:1994;240-245.
33. Trivedy C., Warnakulasuriya K.A.A.S., Tavassoli M., Steingrimsdottir H., Penhallow J., Maher R, et al. p53 aberrations in oral submucous fibrosis and oral squamous cell carcinoma detected by immunocytochemistry and PCR-SSCP. J Oral Pathol Med. 27:1998;72-77.
34. Ibrahim S.O., Vastrand E.N., Johannessen A.C., Idris A.M., Magnusson B., Nilsen R, et al. Mutations of the p53 gene in oral squamous cell carcinomas from Sudanese dippers of nitrosamine-rich Toombak and non-snuff-dippers from the Sudan and Scandinavia. Int J Cancer. 81:1999;527-534.
35. Trizna Z., Scahntz S.P. Hereditary and environmental factors associated with risk and progression of head and neck cancer. Otolaryngol Clin North Amer. 25:1992;1089-1103.
36. Liggett W.H., Sidransky D. Role of the p16 tumor suppressor gene in cancer. J Clin Oncol. 16:1998;1197-1206.
37. Sun S., Pollock P., Liu L. CDKN2A mutation in a non-FAMM kindred with cancers at multiple sites results in a functionally abnormal protein. Int J Cancer. 73:1997;531-536.
38. Yarbrough W., Apelikova O., Pei H. Familial tumor syndrome associated with a germline non-functional p16 allele. JNCI. 88:1996;1489-1490.
39. Lynch HT, Smyrk TC, Watson P, Lanspa SJ, Lynch JF, Lynch PM, et al. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer; an updated review. Gastroenterology 1993;104;1535-49.
40. Cairns P, Sidransky D. Molecular methods for the diagnosis of cancer. Boichim Biophys Acta 1999;1423:C11-C18.
41. Welkoborsky H.J., Hinni M., Dienes H.P., Mann W.J. Potential early markers of carcinogenesis in the mucosa of the head and neck using exfoliative cytology. Ann Otol Rhinol Laryngol. 104:1995;503-510.
42. Huang M.F., Chang Y.C., Liao P.S., Huang T.H., Tsay C.H., Chou M.Y. Loss of heterozygosity of p53 gene of oral cancer detected by exfoliative cytology. Oral Oncology. 35:1999;296-301.
43. Boyle J.O., Mao L., Brennan J.A., Koch W.M., Eisele D.W., Saunders J.R, et al. Gene mutations in saliva as molecular markers for head and neck squamous cell carcinomas. The American Journal of Surgery. 168:1994;429-432.
44. Rosin M.P., Epstein J.B., Berean K., Durham S., Hay J., Cheng X, et al. The use of exfoliative cell samples to map clonal genetic alterations in the epithelium of high-risk patients. Cancer Res. 57:1997;5258-5260.
45. Field J.K., Liloglou T., Xinarianos G., Prime W., Fielding P., Walshaw M.J, Turnbull L, et al. Genetic alterations is bronchial lavage as a potential marker for individuals with a high risk of developing lung cancer. Cancer Research. 59:1999;2690-2695.
46. Lavieille J.P., Lubin R., Soussi T., Reyt E., Brambilla C. Analysis of p53 antibody response in patients with squamous cell carcinomas of the head and neck. Anticancer Res. 16:1996;2385-2388.
47. Bourhis J., Lubin R., Roche B., Koscielny S., Bosq J., Dubois I, et al. Analysis of p53 serum antibodies in patients with head and neck squamous cell carcinoma. J Natl Cancer Inst. 88:1996;1228-1233.
48. Friedrich R.E., Bartel-Friedrich S., Plambeck K., Bahlo M., Klapdor R. p53 auto-antibodies in the sera of patients with oral squamous cell carcinoma. Anticancer Res. 17:1997;3183-3184.
49. Maass J.D., Gottschlich S., Goeroegh T., Lippert B.M., Werner J.A. Head and neck cancer and p53-immunogenicity. Anticancer Res. 17:1997;2873-2874.
50. Tavassoli M., Brunel N., Maher R., Johnson N.W., Soussi T. p53 antibodies in the saliva of patients with squamous cell carcinoma of the oral cavity. Int J Cancer. 78:1998;390-391.
51. Califano J., Ahrendt S.A., Meininger G., Westra W.H., Koch W.M., Sidransky D. Detection of telomerase activity in oral rinses from head and neck squamous cell carcinoma patients. Cancer Res. 56:1996;5720-5722.
52. Brennan J.A., Mao L., Hruban R.H., Boyle J.O.et al. Molecular assessment of histopathological staging in squamous cell carcinoma of the head and neck. New Engl J Med. 332:1995;429-435.
53. Gusterson B.A., Anbazaghan R., Warren W., Midgely C., Lane D.P., O'Hare M.et al. Expression of p53 in premalignant and malignant squamous epithelium. Oncogene. 6:1991;1785-1789.
54. Boyle J.O., Hakim J., Koch W., van der Riet P., Hruban R.H., Roa R.A, et al. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Research. 53:1993;4477-4480.
55. Warnakulasuriya K.A.A.S., Johnson N.W. Expression of the tumor suppressor gene p53 mutant nuclear phosphoprotein in oral carcinoma and potentially malignant oral lesions. J Oral Pathol Med. 21:1992;404-408.
56. Warnakulasuriya K.A.A.S., Johnson N.W. Association of overexpression of p53 oncoprotein with the state of cell proliferation in oral carcinoma. J Oral Pathol Med. 23:1994;246-250.
57. Girod S.C., Krueger G., Paper H.D. p53 and Ki67 expression in preneoplastic and neoplastic lesions of the oral mucosa. Int J Oral Maxillofac Surg. 22:1993;285-288.
58. Sauter E.R., Cleveland D., Trock B., Ridge J.A., Klein-Szanto J.P. p53 is overexpressed in fifty percent of pre-invasive lesions of head and neck epithelium. Carcinogenesis. 15:1994;2269-2274.
59. Slootweg P.J., Koole R., Hordijk G.J. The presence of p53 protein in relation to Ki-67 as cellular proliferation marker in head and neck squamous cell carcinoma and adjacent dysplastic mucosa. Oral Oncol. Eur J Cancer. 30B:1994;138-141.
60. Wood M.W., Medina J.E., Thompson G.C., Houck J.R., Min K.-W. Accumulation of the p53 tumor-suppressor gene product in oral leukoplakia. Otolaryngol Head Neck Surg. 111:1994;758-763.
61. Regezi J.A., Zarbo R.J., Regev E., Pisanty S., Silverman S., Gazit D. p53 protein expression in sequential biopsies of oral dysplasias and in situ carcinomas. J Oral Pathol Med. 24:1995;18-22.
62. Shintani S., Yoshihama Y., Emilio A.R., Matsumura T. Overexpression of p53 is an early event in the tumorigenesis of oral squamous cell carcinomas. Anticancer Res. 15:1995;205-208.
63. Kusama K., Okutsu S., Takeda A., Himiya T., Kojima A., Kidokoro Y.et al. P53 gene alterations and p53 protein in oral epithelial dysplasia and squamous cell carcinoma. J Pathol. 178:1996;415-421.
64. Steingrimsdottir H., Penhallow J., Farzaneh F., Johnson N., Tavassoli M. Detection of p53 mutations in oral cancer samples using a sensitive PCR-based method. Trans Biochem Soc. 25:1997;1997-1999.
65. Cruz I.B., Snijders P.J.F., Meijer C.J., Braakhuis B.J., Snow G.B., Walboomers J.M., Van der Waal I. P53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma. J Pathol. 184:1998;360-368.
66. Ogden G.R., Chisholm D.M., Morris A.M., Stevenson J.H. Overexpression of p53 in normal oral mucosa of oral cancer patients does not necessarily predict further malignant disease. J Pathol. 182:1997;180-184.
67. Hogmo A., Lindskog S., Lindholm J., Kuylenstierna R., Auer G., Munck-Widland E. Preneoplastic oral lesions; the clinical value of image cytometry DNA analysis, p53 and p21/WAF1 expression. Anticancer Res. 18:1998;3645-3650.
68. Mao L., Lee J.S., Fan Y.H., Ro J.Y., Batsakis J.G., Lippman S, et al. Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nature Medicine. 2:1996;682-685.
69. Lydiatt W.M., Davidson B.J., Schantz S., Caruana S., Chaganti R.S.K. 9p21 deletion correlates with recurrence in head and neck cancer. Head Neck. 20:1998;113-118.
70. Van der Reit P., Nawroz H., Hruban R.H., Corio R., Tokino K., Koch W, et al. Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. Cancer Res. 54:1994;1156-1158.
71. Emilion G., Langdon J.D., Speight P., Partridge M. Frequent gene deletions in potentialy malignant oral lesions. Br J Cancer. 73:1996;809-813.
72. Sartor M., Steingrimsdottir H., Elamin F., Gaken J., Warnakulasuriya S., Partridge M, et al. Role of p16/MTS1, cyclin D1 and Rb in primary oral cancer and oral cancer cell lines. Br J Cancer. 80:1999;79-86.
73. Kuo M.Y.P., Lin C.Y., Hahn L.J., Cheng S.J., Chiang C.P. Expression of cyclin D1 is correlated with poor prognosis in patients with areca quid chewing-related oral squamous cell carcinomas in Taiwan. J Oral Pathol Med. 28:1999;165-169.
74. Field J.K. Genomic instability in squamous cell carcinoma of the head and neck. Anticancer Res. 16:1996;2421-2431.
75. Piccinin S., Gasparotto D., Vukosavljevic T., Barzan L., Sulfaro S., Maestro R, et al. Microsatellite instability in squamous cell carcinoma of the head and neck related to field cancerisation phenomena. Br J Cancer. 78:1998;1147-1151.
76. Roz L., Wu C.L., Porter S.R., Scully C., Read A., Speight P.M. Allelic imbalance on chromosome 3p in oral dysplastic lesions: an early event in oral carcinogenesis. Cancer Res. 56:1996;1228-1231.
77. Rowley H., Jones A., Spandidos D., Field J. Definition of a tumor suppressor gene locus on the short arm of chromosome 3 in squamous cell carcinoma of the head and neck by means of microsatellite markers. Arch Otolaryngol Head Neck Surg. 122:1996;497-501.
78. Ishwad C.S., Ferrell R.E., Rossie K.M., Appel B.N., Johnson J.T., Myers E.N.et al. Microsatellite instability in oral cancer. Int J Cancer. 64:1995;332-335.
79. Ishwad C.S., Ferrell R.E., Rossie K.M., Appel B.N., Johnson J.T., Myers E.N.et al. Loss of heterozygosity of the short arm of chromosomes 3 and 9 in oral cancer. Int J Cancer. 69:1996;1-4.
80. Field J.K., Tsiriyotis C., Zoumpourlis V., Howard P., Spandidos D.A., Jones A.S. Allele loss on chromosome 3 in squamous cell carcinoma of the head and neck correlates with poor clinical prognostic indicators. International Journal of Oncology. 4:1994;543-549.
81. Wu C.-L., Sloan P., Read A.P., Harris R., Thakker N. Deletion mapping on the short arm chromosome 3 in squamous cell carcinoma of the oral cavity. Cancer Res. 54:1994;6484-6488.
82. Partridge M., Emilion G., Langdon J.D. LOH at 3p correlates with a poor survival in oral squamous cell carcinoma. Br J Cancer. 73:1996;366-371.
83. Partridge M., Emilion G., Pateromichelakis S., A' Hern R., Lee G., Phillips E, et al. The prognostic significance of allelic imbalance at key chromosomal loci in oral cancer. Br J Cancer. 79:1999;1821-1827.
84. Yeudall W.A., Crawford R.Y., Ensley J.D., Robbins K.C. MTSI/CDK41 is altered in cell lines derived from primary and metastatic oral squamous cell carcinoma. Carcinogenesis. 15:1994;2683-2686.
85. Danahey D.G., Tobin E.J., Schuller D.E., Bier-Laning C.M., Weghorst C.M., Lang J.C. P16 mutation frequency and clinical correlation in head and neck cancer. Acta Otolaryngol. 119:1999;285-288.
86. Nagai M.A., Miracca E.C., Yamamoto L., Kowalski L.P., Brentani R.R. TP53 mutations in upper aerodigestive squamous cell carciomas from a group of Brazilian patients. Am J Surg. 170:1995;492-494.
87. Bourhis J., Bosq J., Wilson G.D., Bressac B., Talbot M., Leridant A.M, et al. Correlation between p53 gene expression and tumor-cell proliferation in oropharyngeal cancer. Int J Cancer. 57:1994;458-462.
88. Gasparini G., Weidnere N., Maluta S., Pozza F., Boracchi P., Mezzetti M.et al. Intratumoral microvessel density and p53 protein: correlation with metastasis in head and neck squamous cells carcinoma. Int J Cancer. 55:1993;739-744.
89. Field J.K., Malliri A., Butt S.A. p53 Over-expression in end stage squamous cell carcinomas of the head and neck: correlates with a very poor clinical outcome. Int J Oncol. 3:1993;431-435.
90. Gluckman J.L., Stambrook P.J., Pavelic Z.P. Prognostic significance of p53 protein accumulation in early stage t1 oral cavity cancer. Oral Oncol, Eur J Cancer. 30B:1994;281.
91. Shin D.M., Lee J.S., Lippman S.M., Lee J.J., Tu Z.N., Choi G.et al. P53 expression: predicting recurrence and second primary tumors in head and neck squamous cell carcinoma. J Natl Cancer Inst. 88:1996;519-529.
92. Burns J.E., Baird M.C., Clark L.J., Burns P.A., Edington K., Chapman C, et al. Gene mutations and increased levels of p53 protein in human squamous cell carcinomas and their cell lines. Br J Cancer. 67:1993;1274-1284.
93. Xu L., Chen Y.T., Huvos A.G., Zlotolow I.M., Rettig W.J., Old L.J, et al. Overexpression of p53 protein in squamous cell carcinomas of head and neck without apparent gene mutations. Diagnostic Molecular Pathology. 3:1994;83-92.
94. Pavelic Z., Gluckman J., Gapany M., Reising J., Craven J., Kelley D, et al. Improved immunohistochemical detection of p53 protein in paraffin-embedded tissues reveals elevated levels in most head and neck and lung carcinomas: correlation of clinicopathological parameters. Anticancer Res. 12:1992;1389-1394.
95. Nishioka H., Hiasa Y., Isao H., Yoshiteru K., Kitahori Y., Konishi N. Immunohistochemical detection of p53 oncoprotein in human oral squamous cell carcinomas and leukoplakias: comparison with proliferating cell nuclear antigen staining and correlation with clinicopathological findings. Oncology. 50:1993;426-429.
96. Lavieille J.P., Brambilla E., Riva-Lavieille C., Reyt E., Charachon R., Brambilla C. Immunohistochemical detection of p53 protein in preneoplastic lesions and squamous cell carcinoma of the head and neck. Acta Otolaryngol. 115:1995;334-339.
97. Sauter E.R., Ridge J.A., Gordon J., Elsenberg B.L. p53 Over-expression correlates with increased survival in patients with squamous carcinoma of the tongue base. Am J Surg. 164:1992;651-653.
98. Gapany M., Pavelic Z.P., Gapany S.R., Pavelic L., Li Y.G., Craven J.M. Relationship between immunohistochemically detectable p53 protein and prognostic factors in head and neck tumors. Cancer Detect Prevent. 17:1993;379-386.
99. Leedy D.A., Trune D.R., Kronz J.D., Weidner N., Cohen J.I. Tumor angiogenesis, the p53 antigen and cervical metastasis in squamous cell carcinoma of the tongue. Otolaryngol Head Neck Surg. 111:1994;417-422.
100. Mukhopadhyay D., Chatterjee R., Chakraborty R.N. Association of p53 expression with cytokinetics and HPV capsid antigen prevalence in oral carcinomas. Cancer Lett. 87:1994;99-105.
101. Schipper J.H., Kelker W. Die expression der tumorsuppressor-gene p53 und Rb bei patienten mit plattenepithelkarzinomen im Kopf/Halsbereich. HNO. 42:1994;270-274.
102. Ahomadegbe J.C., Barrois M., Fogel S., LeBihan M.L., Douc-Rary L., Duvillard P. High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent, protein overexpression in normal epithelium and in early non-invasive lesions. Oncogene. 10:1995;1217-1227.
103. Nylander K., Stenling R., Gustafsson H., Zackrisson B., Roos G. p53 expression and cell proliferation in squamous cell carcinomas of the head and neck. Cancer. 75:1995a;87-93.
104. Nylander K., Nilsson P., Mehle C., Roos G. p53 mutations, protein expression and cell proliferation in squamous cell carcinomas of the head and neck. Cancer. 71:1995b;826-830.
105. Stoll C., Baretton G., Lohrs U. The influence of p53 and associated factors on the outcome of patients with oral squamous cell carcinoma. Virchows Arch. 433:1998;427-433.
106. Dahse R., Fiedler W., Von Eggeling F., Schimmel B., Koscielny S., Beleittes E, et al. p53 genotyping- an effective concept for molecular testing of head and neck cancer? Int J Mol Med. 4:1999;279-283.
107. Ma L., Ronai A., Riede U.N., Kohler G. Clinical implications of screening p53 gene mutations in head and neck squamous cell carcinomas. J Cancer Res Clin Oncol. 124:1998;389-396.
108. Mineta H., Borg A., Dictor M., Wahlberg P., Akervall J., Wennerberg J. p53 mutation, but not p53 overexpression, correlates with survival in head and neck squamous cell carcinoma. Br J Cancer. 78:1998;1084-1090.
109. Gapany M., Pavelic Z.P., Kelley D.J., Pavelic L., Gapany S.R., Craven J.M, et al. Immunohistochemical detection, of c-myc protein in head and neck tumors. Arch Otolaryngol Head Neck Surg. 120:1994;255-259.
110. Wang X.L., Uzawa K., Nakanishi H., Tanzawa H., Sato T. Allelic imbalance on the long arm of chromosome 5 in oral squamous cell carcinoma. Int J Oncol. 10:1997;535-538.
111. Ogawara K., Miyakawa A., Shiiba M., Uzawa K., Watanabe T., Wang X.L, et al. Allelic loss of chromosome 13q14.3 in human oral cancer; correlation with lymph node metastasis. Int J Cancer. 79:1998;312-317.
112. Wang X., Gleich L., Pavelic Z.P., Li Y.Q., Gale N., Hunt S. Cervical metastases of head and neck squamous cell carcinoma correlate with loss of heterozygosity on chromosome 16q. Int J Oncol. 14:1999;557-561.
113. Pearlstein R.P., Benninger M.S., Rybicki B.A., Torres F.X., Van Dyke D.L. Preliminary study of 18q loss of heterozygosity and poor survival in patients with stage III head and neck cancer. On-Line Interact J Otolaryngol. 11:1997;1-6.
114. Pearlstein R.P., Benninger M.S., Carey T.E., Zarbo R.J., Rybicki B.A., Torres F.X. Loss of 18q predicts poor survival of patients with squamous cell carcinoma of the head and neck. Genes, Chromosomes, Cancer. 21:1998;333-339.
115. Watanabe T., Wang X.L., Miyakawa A., Shiiba M., Imai Y., Sato T., Tanzawa H. Mutational state of tumor suppressor genes (DCC, DPC4) and alteration on chromosome 18q21 in human oral cancer. Int J Oncol. 11:1997;1287-1290.
116. Agarwal S., Mathur M., Srivastava A., Ralhan R. MDM2/p53 co-expression in oral premalignant and malignant lesions: potential prognostic implications. Oral Oncol. 35:1999;209-216.
117. Ng I.O.L., Lam K.Y., Ng M., Regezi J.A. Expression of p21/waf1 in oral squamous cell carcinomas- correlation with p53 and mdm2 and cellular proliferation index. Oral Oncol. 35:1999;63-69.
118. Venkatesan T.K., Kuropkat C., Caldarelli D.D., Panje W.R., Hutchinson J.C., Chen S. Prognostic significance of p27 expression on carcinoma of the oral cavity and oropharynx. Laryngoscope. 109:1999;1329-1333.
119. Kudo Y., Takata T., Yasui W., Ogawa I., Miyauchi M., Takekoshi T, et al. Reduced expression of cyclin-dependent kinase inhibitor p27 is an indicator of malignant behavior in oral squamous cell carcinoma. Cancer. 83:1998;2447-2455.
120. Mineta H., Miura K., Suzuki I., Takebayashi S., Amano H., Araki K. Low p27 expression correlates with poor prognosis for patients with oral tongue squamous cell carcinoma. Cancer. 85:1999;1011-1017.
121. Somers K.D., Merrick M.A., Lopez M.E., Incofnito L.S., Schechter G.L., Casey G. Frequent p53 mutations in head and neck cancer. Cancer Res. 52:1992;5997-6000.
122. Somers K.D., Schechter G.L. Genetic alterations in head and neck cancer. Otolaryngol Clin North Am. 25:1992;1065-1071.
123. Muller D., Millon R., Lidereau R., Engelmann A., Bronner G., Flesch H. Frequent amplification of 11q13 DNA markers is associated with lymph node involvement in human head and neck squamous cell carcinomas. Oral Oncol Eur, J Cancer. 30B:1994;113-120.
124. Lammie G.A., Fantl V., Smith R., Schuuring E.D., Brookes S., Michalides R. D11S287, a purative oncogene in chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BDL-1. Oncogene. 6:1991;439-444.
125. Klijanienko J., Bianchi A.B., Cvitkovic E., Janot F., Luboinski B., Conti C.J. Unexpected PRAD-1 amplification in multiple simultaneous localizations of squamous cell carcinoma of the head and neck. Eur J Cancer. 29:1993;563-564.
126. Williams M.E., Gaffey M.J., Weiss L.M., Wilczynski S.P., Schuuring E., Levine P.A. Chromosome 11Q13 amplification in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 119:1993;1238-1243.
127. Callender T., El-Naggar A.K., Lee M.S., Frankenthaler R., Luna M.A., Batsakis J.G. PRAD-1 (CCND1)/Cyclin D1 Oncogene amplification in primary head and neck squamous cell carcinoma. Cancer. 74:1994;152-158.
128. Lucas J.M., Mountain R.E., Gramza A.W., Schuller D.E., Wilkie N.M., Lang J.C. Expression of cyclin D1 in squamous cell carcinomas of the head and neck. International Journal of Oncology. 5:1994;469-472.
129. Parise O., Janot F., Guerry R. Chromosome 11q13 gene amplifications in head and neck squamous cell carcinomas: relation with lymph node invasion. Int J Oncol. 5:1994;309-313.
130. Kyomoto R., Kumazawa H., Toda Y., Sakaida N., Okamura A., Iwanaga M, et al Cyclin-D1-gene amplification is a more potent prognostic factor than its protein over-expression in human head-and-neck squamous-cell carcinoma. Int J Cancer. 74:1997;576-581.
131. Michalides R.J.A.M., van Veelen N.M.J., Kristel P.M.P., Hart A.A.M., Loftus B.M., Hilgers F.J.M, et al. Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 123:1997;497-502.
132. Gaffey M.J., Iezzoni J.C., Meredit S.D.et al. Cyclin D1 (PRAD1, CCND1) and glutathione-S-Transferase π gene expression in head and neck squamous cell carcinoma. Hum Pathol. 26:1995;1221-1226.
133. Fortin A., Guerry M., Guerry R., Talbot M., Parise O., Schwaab G, et al. Chromosome 11q13 gene amplification in oral and oropharyngeal carcinomas; no correlation with subclinical lymph node invasion and disease recurrence. Clin Cancer Res. 3:1997;1609-1614.
134. Field J.K., Yiagnisis M., Spandidos D.A., Gosney J.R., Papadimitriou K., Vaughan E.D, et al. Low levels of ras p21 oncogene expression correlates with clinical outcome in head and neck squamous cell carcinoma. Eur J Surg Oncol. 18:1992;168-176.
135. Santini J., Formento J.L., Frauncoual M., Milano G., Schneider M., Dassonville O, et al. Characterization quantification and potential clinical value of epidermal growth factor receptor in head and neck squamous cell carcinomas. Head Neck. 13:1991;132-139.
136. Saranath D., Panchal R.G., Nair R., Mehta A.R., Sanghavi V.D., Deo M.G. Amplification and overexpression of epidermal growth factor receptor gene in human oropharyngeal cancer. Oral Oncol Eur J Cancer. 28B:1992;139-143.
137. Storkel S., Reichart T., Reiffen K.A., Wagner L. EGFR and PCNA expression in oral squamous cell carcinomas - a valuable tool in estimating the patient's prognosis. Oral Oncol Eur J Cancer. 29B:1993;273-277.
138. Rubin Grandis J., Melhem M.F., Gooding W.E., Day R., Holst V.A., Wagener M.M, et al. Levels of TGF-α and EGFR protein in head and neck squamous cell carcinoma and patient survival. JNCI. 90:1998;824-831.
139. Werkmeister R., Brandt B., Joos U. Clinical relevance of erbB-1 and-2 oncogenes in oral carcinomas. Oral Oncology. 36:2000;100-105.
140. Yao L., Iwai M., Furuta I. Correlations of bcl-2 and p53 expression with the clinicopathological features in tongue squamous cell carcinomas. Oral Oncology. 35:1999;56-62.
141. Staibano S., Mignogna M.D., LoMuzio L., DiAlberti L., DiNatale E., Lucariello A, et al. Overexpression of cyclin-D1, bcl-2, and bax proteins, proliferating cell nuclear antigen (PCNA) and DNA-ploidy in squamous cell carcinoma of the oral cavity. Hum Pathol. 29:1998;1189-1194.
142. Ito T., Fujieda S., Tsuzuki H., Sunaga H., Fan G., Sugimoto C, et al. Decreased expression of Bax is correlated with poor prognosis in oral and oropharyngeal carcinoma. Cancer Lett. 140:1999;81-91.
143. Xie X., Clausen O.P., De Angelis P., Boysen M. The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in oral squamous cell carcinoma of the tongue. Cancer. 86:1999;913-920.
144. Field J.K., Spandidos D.A., Stell P.M., Vaughan E.D., Evan G.I., Moore J.P. Elevated expression of the c-myc oncoprotein correlates with poor prognosis in head and neck squamous-cell carcinoman. Oncogene. 4:1989;1463-1468.
145. Yanagawa T., Harada H., Iwasa S., Tabuchi K., Omura K., Suzuki H, et al. c-Abl expression in oral squamous cell carcinoma. Oral Oncology. 36:2000;89-94.
146. LoMuzio L., Mignogna M.D., Pannone G., Staibano S., Procaccini M., Serpico R, et al. The NM23 gene and its expression in oral squamous cell carcinoma. Oncology Rep. 6:1999;747-751.
147. Gleich L.L., Li Y.Q., Wang X., Stambrook P.J., Gluckman J.L. Variable genetic alterations and survival in head and neck cancer. Arch Otolaryngol Head Neck Surg. 125:1999;949-952.
148. Vogelstein B., Fearon E.R., Kearn S.E., Hamilton S.R., Preisinger A.C., Nakamura Y, et al. Allelotype of colorectal carcinomas. Science. 244:1989;207-211.
149. Mao L., El-Naggar A.K., Papadimitrakopoulou V., Shin D.M., Shin H.C., Fan Y, et al. Pgenotype and genotype of advanced premalignant lesions after chemopreventive therapy. JNCI. 90:1998;1545-1551.
150. Lotan R., Xu X.C., Lippman S.M., Ro J.Y., Lee J.S., Lee J.J, et al. Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin. New Engl J Med. 332:1995;1405-1410.
151. Brachman D.G., Beckett M., Graves D., Haraf D., Vokes E., Weichselbaum R.R. p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines. Cancer Research. 53:1993;3667-3669.
152. Pekkola-Heino K., Servomaa K., Kiuru A., Grenman R. Increased radiosensitivity is associated with p53 mutations in cell lines derived from oral cavity carcinoma. Acta Otolaryngol (Stockh). 116:1996;3341-3344.
153. Tatemoto Y., Osaki T., Yoneda K., Yamamoto T., Ueta E., Kimura T. Expression of p53 and p21 proteins in oral squamous cell carcinoma: correlation with lymph node metastasis and response to chemoradiotherapy. Pathol Res Pract. 194:1998;821-830.
154. Taylor D., Koch W.M., Zahurak M., Shah K., Sidransky D., Westra W.H. Immunohistochemical detection of p53 protein accumulation in head and neck cancer: correlation with p53 gene alterations. Hum Pathol. 30:1999;1221-1225.
155. Zhang L., Epstein J., Band P., Berean K., Hay J., Cheng X, et al. Local tumor recurrence or emergence of a new primary lesion? A molecular analysis. J Oral Pathol Med. 28:1999;381-384.
156. Scholes AG., Woolgar J.A., Boyle M.A., Brown J.S., Vaughan E.D., Hart C.A, et al. Synchronous oral carcinomas: independent or common clonal origin? Cancer Res. 58:1998;2003-2006.
157. Califano J., Westra W.H., Koch W., Meininger G., Reed A., Yip L, et al. Unknown primary head and neck squamous cell carcinoma; molecular identification of the site of origin. JNCI. 91:1999;599-604.
158. Leong P.P., Rezai B., Koch W.M., Reed A., Eisele D., Lee D.J, et al. Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma. JNCI. 90:1998;972-977.
159. Shillitoe E.J., Lapeyre J.N., Adler-Storthz K. Gene therapy - its potential in the management of oral cancer. Eur J Cancer B Oral Oncol. 30B:1994;143-154.
160. Shillitoe E.J. Gene therapy for oral cancer: recent progress in research. Oral Oncol. 34:1998;157-160.
161. Clayman G.L., Trapnell B.C., Mittereder N., Liu T.J., Eicher S., Zhang S, et al. Transduction of normal and malignant oral epithelium by an adenovirus vector: the effect of dose and treatment time on transduction efficiency and tissue penetration. Cancer Gene Ther. 2:1995;105-111.
162. Blackwell J.L., Miller C.R., Douglas J.T., Li H., Reynolds P.N., Carroll W.R, et al. Retargetting to EGFR enhances adenovirus infection efficiency of squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 125:1999;856-863.
163. Carew J.F., Kooby D.A., Halterman M.W., Federoff H.J., Fong Y. Selective infection and cytolysis of human head and neck squamous cell carcinoma with sparing of normal mucosa by a cytotoxic herpes simplex virus type 1 (G207). Hum Gene Ther. 10:1999;1599-1606.
164. Carew J.F., Federoff H.J., Halterman M.W., Kraus D.H., Savage H., Sacks P.G, et al. Efficient gene transfer to human squamous cell carcinomas by herpes simplex virus type 1 amplicon vectors. Am J Surg. 176:1998;404-408.
165. Sewell D.A., Li D., Duan L., Schwartz M.R., O'Malley B.W. Jr. Optimizing suicide gene therapy for head and neck cancer. Laryngoscope. 107:1997;1490-1495.
166. Goebel E.A., Davidson B.L., Zabner J., Graham S.M., Kern J.A. Adenovirus-mediated gene therapy for head and neck squamous cell carcinomas. Ann Otol Rhinol Laryngol. 105:1996;562-567.
167. Sewell D.A., Li D., Duan L., Westra W.H., O'Malley B.W. Jr. Safety of in vivo adenovirus-mediated thymidine kinase treatment of oral cancer. Arch Otolaryngol Head Neck Surg. 123:1997;1298-1302.
168. O'Malley B.W. Jr., Li D., Buckner A., Duan L., Woo S.L., Pardoll D.M. Limitations of adenovirus-mediated interleukin-2 gene therapy for oral cancer. Laryngoscope. 109:1999;389-395.
169. O'Malley B.W., Cope K.A., Chen S.H., Li D., Schwarta M.R., Woo S.L. Combination gene therapy for oral cancer in a murine model. Cancer Res. 15(56):1996;1737-1741.
170. Liu T.-J., Zhang W.-W., Taylor D.L., Roth J.A., Goepfert H., Clayman G.L. Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus. Cancer Research. 54:1994;3662-3667.
171. Takahashi R., Inagaki T., Matsuwari S., Fujioka M., Maeda S., Ijuhin N.et al. Transfection of wild-type TP53 induced differentiation in human gingival carcinoma cells. Eur J Cancer. 32A:1996;533-539.
172. Clayman G.L., Liu T.J., Overholt S.M., Mobley S.R., Wang M., Janot F, et al. Gene therapy for head and neck cancer. Arch Otolaryngol Head Neck Surg. 122:1996;489-493.
173. Lee G., Hong H.J., You Y.O., Bang E.H., Kook J.K., Min B.M. Effect of p53 gene transfer on the cell proliferation and cell cycle progression in a human oral cancer cell line with p53 mutation. Int J Oral Biol. 23:1998;189-199.
174. Chang E.H., Yang Y.J., Hao Z., Murphy G., Rait A., Fee W.E, et al. Restoration of the G1 checkpoint and the apoptotic pathway mediated by wild-type p53 sensitises squamous cell carcinoma of the head and neck to radiotherapy. Arch Orolaryngol Head Neck Surg. 123:1997;507-512.
175. Cardinali M., Jakus J., Shah S., Ensley J.F., Robbins K.C., Yeudall W.A. p21(WAF1/Cip1) retards the growth of human squamous cell carcinomas in vivo. Oral Oncol. 34:1998;211-218.
176. Clayman G.L., El-Naggar A.K., Lippman S.M., Henderson Y.C., Frederick M., Merritt J.A, et al. Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma. J Clin Oncol. 16:1998;2221-2232.
177. Liggett W.H., Sewell D.A., Rocco J., Ahrendt S.A., Koch W., Sidransky D. P16 and p16β are potent growth suppressors of head and neck squamous carcinoma cells in vitro. Cancer Res. 56:1996;4119-4123.
178. Uzawa N., Yoshida M.A., Oshimura M., Ikeuchi T. Suppression of tumorigenicity in three different cell lines of human oral squamous cell carcinoma by introduction of chromosome 3p via microcell-mediated chromosome transfer. Oncogene. 11:1995;1997-2004.
179. Liu R., Oberley T.D., Oberley L.W. Transfection and expression of MnSOD cDNA decreases tumor malignancy of human oral squamous carcinoma SCC-25 cells. Hum Gene Ther. 20:1997;585-595.
180. Fujii M. Growth suppression of squamous cell carcinoma cell lines by PKCs - possible application to gene therapy. Kokubyo Gakkai Zasshi. 64:1997;52-66.
181. Liu T.-J., Wang M., Breau R.L., Henderson Y., El-Naggar A.K., Steck K.D, et al. Apoptosis induction by E2F-1 via adenoviral-mediated gene transfer results in growth suppression of head and neck squamous cell carcinoma cell lines. Cancer Gene Therapy. 6:1999;163-171.
182. Todd R., Donoff B.R., Wong D.T.W. The molecular biology of oral carcinogenesis; toward a tumor progression model. J Oral Maxillofac Surg. 55:1997;613-623.
183. Imai F.L., Uzawa K., Shiiba M., Watanabe T., Miya T., Kubosawa H, et al. Evidence of multi-step oncogenesis of oral squamous cell carcinoma. Oncology Reports. 5:1998;1489-1491.
184. Scully C., Field J.K. Genetic aberrations in squamous cell carcinoma of the head and neck (SCCHN), with reference to oral carcinoma (Review). Int J Oncol. 10:1997;5-21.